Drawing for ADITXT IMMUNE HEALTH

USPTO serial 90612657

ADITXT IMMUNE HEALTH

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KHAN, ASMAT A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADITXT IMMUNE HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jared M. Barrett

Jared M. Barrett SEED IP LAW GROUP LLP701 5TH AVENUE, SUITE 5400SEATTLE, WA 98104United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and therapeutic agents for reprogramming the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells; pharmaceutical preparations and therapeutic agents for inducing immune toleranceACTIVE—
042Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research; medical laboratory servicesACTIVE—
044Health care services, namely, medical analysis services for diagnostic, treatment and information purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic, treatment and information purposes; advisory services relating to health; providing information in the field of healthACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 19, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 19, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 20, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2024EX4GSOU EXTENSION 4 GRANTED—
Jan 18, 2024EXT4SOU EXTENSION 4 FILED—
Jan 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 19, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 17, 2023EX3GSOU EXTENSION 3 GRANTED—
Jul 17, 2023EXT3SOU EXTENSION 3 FILED—
Jul 17, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 19, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 17, 2023EX2GSOU EXTENSION 2 GRANTED—
Jan 17, 2023EXT2SOU EXTENSION 2 FILED—
Jan 17, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 20, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 18, 2022EX1GSOU EXTENSION 1 GRANTED—
Jul 18, 2022EXT1SOU EXTENSION 1 FILED—
Jul 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 23, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 23, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 18, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 23, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 23, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 3, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 20, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Oct 20, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 20, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 20, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 20, 2021GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 20, 2021GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 20, 2021CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 20, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 12, 2021PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 27, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 27, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 27, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 27, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 27, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 24, 2021DOCKASSIGNED TO EXAMINER—
Sep 22, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 9, 2021MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 2, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance